Ikarian Capital’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$817K Hold
213,865
0.09% 113
2026
Q1
$1.13M Hold
213,865
0.09% 110
2025
Q4
$1.65M Buy
+213,865
New +$1.91M 0.13% 110
2022
Q3
Sell
-19,002
Closed -$265K 161
2022
Q2
$265K Sell
19,002
-37,500
-66% -$597K 0.05% 111
2022
Q1
$956K Buy
56,502
+3,388
+6% +$58.3K 0.13% 102
2021
Q4
$1.31M Sell
53,114
-49,167
-48% -$1.55M 0.19% 86
2021
Q3
$3.78M Sell
102,281
-13,919
-12% -$511K 0.27% 83
2021
Q2
$5.67M Sell
116,200
-108,333
-48% -$4.52M 0.46% 60
2021
Q1
$6.66M Buy
224,533
+36,650
+20% +$1.03M 0.22% 100
2020
Q4
$4.8M Buy
187,883
+70,106
+60% +$1.41M 0.21% 96
2020
Q3
$1.71M Sell
117,777
-41,667
-26% -$690K 0.12% 117
2020
Q2
$3.29M Sell
159,444
-278,258
-64% -$7.36M 0.26% 84
2020
Q1
$13.9M Buy
+437,702
New +$11M 1.04% 23

Other funds holding VSTM

Ikarian Capital's VSTM Position: Q2 2026 in Review

Ikarian Capital held its Verastem (VSTM) position steady in Q2 2026 at 213,865 shares worth $817K. The position accounts for 0.09% of the portfolio, ranked #113.

Ikarian Capital first reported a position in VSTM in Q1 2020 and has held it in 13 quarters since. The position peaked at $13.9M in Q1 2020. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Ikarian Capital held 213,865 shares of Verastem worth $817K as of Q2 2026.
  • Ikarian Capital left its Verastem share count unchanged in Q2 2026.
  • Verastem made up 0.09% of Ikarian Capital's portfolio in Q2 2026, its #113 holding.
  • Ikarian Capital first reported a position in Verastem in Q1 2020 and has held it in 13 quarters since.
  • Ikarian Capital's Verastem position peaked at $13.9M in Q1 2020.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.